157 related articles for article (PubMed ID: 28817813)
1. The Effect of Tegafur-Uracil on Survival in T Categories as Defined in the Eighth Edition of the TNM Classification: An Exploratory Analysis of Postoperative Adjuvant Tegafur-Uracil on Survival in Patients with Adenocarcinoma of the Lung.
Tsuboi M; Hamada C; Kato H; Ohta M
Chemotherapy; 2017; 62(6):357-360. PubMed ID: 28817813
[TBL] [Abstract][Full Text] [Related]
2. Effect of postoperative adjuvant chemotherapy with tegafur-uracil on survival in patients with stage IA non-small cell lung cancer: an exploratory analysis from a meta-analysis of six randomized controlled trials.
Hamada C; Tsuboi M; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Thorac Oncol; 2009 Dec; 4(12):1511-6. PubMed ID: 19875974
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Kato H; Ichinose Y; Ohta M; Hata E; Tsubota N; Tada H; Watanabe Y; Wada H; Tsuboi M; Hamajima N; Ohta M;
N Engl J Med; 2004 Apr; 350(17):1713-21. PubMed ID: 15102997
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant tegafur-uracil (UFT) or S-1 monotherapy for advanced gastric cancer: a single center experience.
Yen HH; Chen CN; Yeh CC; Lai IR
World J Surg Oncol; 2021 Apr; 19(1):124. PubMed ID: 33865416
[TBL] [Abstract][Full Text] [Related]
6. Enhanced induction of apoptosis in lung adenocarcinoma after preoperative chemotherapy with tegafur and uracil (UFT).
Morio A; Miyamoto H; Izumi H; Futagawa T; Oh T; Yamazaki A; Konno H
Surg Today; 2004; 34(10):822-7. PubMed ID: 15449150
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral gene expression of 5-fluorouracil pharmacokinetics-related enzymes in stage I and II non-small cell lung cancer patients treated with uracil-tegafur after surgery: a prospective multi-institutional study in Japan.
Eguchi K; Oyama T; Tajima A; Abiko T; Sawafuji M; Horio H; Hashizume T; Matsutani N; Kato R; Nakayama M; Kawamura M; Kobayashi K
Lung Cancer; 2015 Jan; 87(1):53-8. PubMed ID: 25468199
[TBL] [Abstract][Full Text] [Related]
8. Uracil-tegafur in early-stage lung cancer.
Altundag O; Altundag K; Gunduz M
N Engl J Med; 2004 Aug; 351(7):713-4; author reply 713-4. PubMed ID: 15306675
[No Abstract] [Full Text] [Related]
9. Retrospective study of efficacy of adjuvant chemotherapy using tegafur-uracil in patients with non-small cell lung cancer with primary tumor size of 4.1-5.0 cm.
Adachi H; Nishii T; Yamamoto T; Nagashima T; Ishikawa Y; Ando K; Woo T; Maehara T; Nakayama H; Masuda M
J Thorac Dis; 2019 Jul; 11(7):3103-3111. PubMed ID: 31463139
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Suehisa H; Toyooka S; Hotta K; Uchida A; Soh J; Fujiwara Y; Matsuo K; Ouchida M; Takata M; Kiura K; Date H
J Clin Oncol; 2007 Sep; 25(25):3952-7. PubMed ID: 17761979
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant therapy with protein-bound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial.
Ohwada S; Kawate S; Ikeya T; Yokomori T; Kusaba T; Roppongi T; Takahashi T; Nakamura S; Kawashima Y; Nakajima T; Morishita Y;
Dis Colon Rectum; 2003 Aug; 46(8):1060-8. PubMed ID: 12907900
[TBL] [Abstract][Full Text] [Related]
12. Alpha-actinin-4 (ACTN4) gene amplification is a predictive biomarker for adjuvant chemotherapy with tegafur/uracil in stage I lung adenocarcinomas.
Noro R; Honda K; Nagashima K; Motoi N; Kunugi S; Matsubayashi J; Takeuchi S; Shiraishi H; Okano T; Kashiro A; Meng X; Yoshida Y; Watanabe S; Usuda J; Inoue T; Wilber H; Ikeda N; Seike M; Gemma A; Kubota K
Cancer Sci; 2022 Mar; 113(3):1002-1009. PubMed ID: 34845792
[TBL] [Abstract][Full Text] [Related]
13. Uracil-tegafur in early-stage lung cancer.
Graziano F
N Engl J Med; 2004 Aug; 351(7):713-4; author reply 713-4. PubMed ID: 15309743
[No Abstract] [Full Text] [Related]
14. Prognostic factors of pathologic stage IB non-small cell lung cancer.
Yano M; Sasaki H; Moriyama S; Kawano O; Hikosaka Y; Fujii Y
Ann Thorac Cardiovasc Surg; 2011; 17(1):58-62. PubMed ID: 21587131
[TBL] [Abstract][Full Text] [Related]
15. Oral uracil-tegafur compared with intravenous chemotherapy as adjuvant therapy for resected early-stage non-small cell lung cancer patients.
Liang SK; Wu CW; Chang CI; Keng LT; Lee MR; Wang JY; Ko JC; Liao WY; Chen KY; Ho CC; Shih JY; Yu CJ
Cancer Med; 2023 Sep; 12(17):17993-18004. PubMed ID: 37559409
[TBL] [Abstract][Full Text] [Related]
16. Benefit of Uracil-Tegafur Used as a Postoperative Adjuvant Chemotherapy for Stage IIA Colon Cancer.
Chen PH; Jhou HJ; Chung CH; Wu YY; Huang TC; Lee CH; Chien WC; Chen JH
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676634
[No Abstract] [Full Text] [Related]
17. Verification of the newly proposed T category (seventh edition of the tumor, node, and metastasis classification) from a clinicopathological viewpoint in non-small cell lung cancer-special reference to tumor size.
Yano T; Morodomi Y; Ito K; Yoshida T; Haro A; Shoji F; Koga T; Maehara Y
J Thorac Oncol; 2010 Jan; 5(1):45-8. PubMed ID: 19884855
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer.
Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H
J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of oral tegafur-uracil as maintenance therapy following intravenous 5-fluorouracil chemotherapy in stage III colon cancer.
Hong KD; Lee SI; Moon HY
Hepatogastroenterology; 2012; 59(113):104-7. PubMed ID: 22251527
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis and the efficacy of postoperative administration of UFT in pathologic stage I non-small cell lung cancer.
Tanaka F; Yanagihara K; Otake Y; Miyahara R; Wada H
Cancer Sci; 2004 Apr; 95(4):371-6. PubMed ID: 15072598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
